ENTRY       D09337                      Drug
NAME        Elotuzumab (USAN);
            Elotuzumab (genetical recombination) (JAN);
            Empliciti (TN)
PRODUCT     EMPLICITI (E.R. Squibb & Sons)
FORMULA     C6476H9982N1714O2016S42
EXACT_MASS  145361.9532
MOL_WEIGHT  145451.5545
REMARK      Therapeutic category: 4291
            ATC code: L01FX08
            Product: D09337<JP/US>
EFFICACY    Antineoplastic, Anti-SLAMF7 antibody
  DISEASE   Multiple myeloma [DS:H00010]
  TYPE      Monoclonal antibody
TARGET      SLAMF7 (CD319) [HSA:57823] [KO:K06733]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
                L01FX Other monoclonal antibodies and antibody drug conjugates
                 L01FX08 Elotuzumab
                  D09337  Elotuzumab (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Monoclonal Antibody/Antibody-Drug Conjugate
               Elotuzumab
                D09337  Elotuzumab (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D09337  Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               CD2 family
                SLAMF7 (CD319)
                 D09337  Elotuzumab (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09337
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09337
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09337
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09337
DBLINKS     CAS: 915296-00-3
            PubChem: 96026017
///
